Smart Intraoperative Reminder to Implement Safety Principles in Laparoscopic Cholecystectomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIHU Strasbourg

About this trial

The Critical View of Safety (CVS) is universally recommended to prevent bile duct injuries in laparoscopic cholecystectomy. However, CVS is underutilized and bile duct injuries are not decreasing. The CVS-Notifier SaMD (Software as a Medical Device) reminds surgeons to verify the CVS before dividing the cystic duct, as recommended by guidelines. It is hypothesized that this systematic and timely reminder could improve the implementation of CVS without disturbing surgical workflows.

Eligibility criteria

Qualifiers

Man or woman over 18 years old.

Patient presenting with benign gallbladder disease requiring an elective laparoscopic cholecystectomy.

Patient without contraindications to anaesthesia or laparoscopic cholecystectomy surgery.

Patients capable of understanding and providing their written consent to the study.

Disqualifiers

Patients presenting with malignant gallbladder disease requiring an elective laparoscopic cholecystectomy.

Pregnant or lactating patient.

Patient in exclusion period (determined by a previous or a current study).

Patient under guardianship or trusteeship.

Trial design

Treatments tested in this trial

  • CVS-Notifier SaMD

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators

IHU Strasbourg

Lead sponsor

Scialytics SAS

Collaborator